Novel biomarkers identifying hypertrophic cardiomyopathy and its obstructive variant based on targeted amino acid metabolomics

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an underdiagnosed genetic heart disease worldwide. The management and prognosis of obstructive HCM (HOCM) and non-obstructive HCM (HNCM) are quite different, but it also remains challenging to discriminate these two subtypes. HCM is characterized by d...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lanyan, Wang, Bo, Zhang, Fuyang, Gao, Chao, Hu, Guangyu, Zhou, Mengyao, Wang, Rutao, Zhao, Hang, Yan, Wenjun, Zhang, Ling, Ma, Zhiling, Yang, Weiping, Guo, Xiong, Huang, Chong, Cui, Zhe, Sun, Fangfang, Song, Dandan, Liu, Liwen, Tao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746752/
https://www.ncbi.nlm.nih.gov/pubmed/36156511
http://dx.doi.org/10.1097/CM9.0000000000002279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746752/
https://www.ncbi.nlm.nih.gov/pubmed/36156511
http://dx.doi.org/10.1097/CM9.0000000000002279

Ejemplares similares